Theraclion touts Echopulse thyroid nodule treatment results
Theraclion says its Echopulse has shown improved outcomes when treating thyroid nodules when compared to surgical treatment, according to new published data.
Three studies – led byDr. Brian Hung-Hin Lang, chief of the endocrine surgery division at Queen Mary University Hospital in Hong Kong – showed the efficiency of using the Echopulse for non-invasive treatment of benign thyroid nodules and compared it to surgery, according to Theraclion.
The study had 43 participants who went through HIFU treatment using the Echopulse and 103 participants who had surgical hemithyroidectomy. The results showed that there was a significantly lower occurrence of subclinical hypothyroidism, better symptoms improvement score, shorter hospital stays and better voice quality after one month in patients who had the HIFU treatment.
The second study focused treating symptomatic benign thyroid nodules. After a 12 month follow-up, patients had average volume reduction of 68.97%, significantly better volume reduction, better symptoms reduction and an improvement in Quality of Life scores.
HIFU treatment rarely changed underlying thyroid functions in 83 patients. hyperthyroidism. Only 1 patient who previously had lobectomy developed hypothyroidism.
“These studies demonstrate that HIFU treatment is not only effective in terms of volume reduction of symptomatic benign thyroid nodules but also in relief of symptoms while being safe.
This fits my life time goal of reducing unnecessary surgery when a viable non-invasive method is a first line alternative.
Go to Europe for HIFU now while we wait for FDA approval in the USA. Call Matt at 310-393-8860 for details of our evaluation qand referral service to HIFU centers in Europe and Asia.
Richard Guttler MD,FACE,ECNU